Exact Sciences
EXAS
#1705
Rank
NZ$17.03 B
Marketcap
$92.06
Share price
1.17%
Change (1 day)
-14.44%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.72. In 2022 the company made an earnings per share (EPS) of -$6.07 a decrease over its 2021 EPS that were of -$5.93.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.54-58.18%
2022-$6.072.31%
2021-$5.93-37.09%
2020-$9.43674.65%
2019-$1.22-50.69%
2018-$2.4744%
2017-$1.71-39.39%
2016-$2.83-2.94%
2015-$2.9137.1%
2014-$2.1379.71%
2013-$1.18-21.59%
2012-$1.5162.96%
2011-$0.9392.86%
2010-$0.48-3.45%
2009-$0.50-19.44%
2008-$0.62-18.18%
2007-$0.75-10.2%
2006-$0.84-10.91%
2005-$0.94-24.66%
2004-$1.25-51.33%
2003-$2.57-7.41%
2002-$2.7811.72%
2001-$2.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.21 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.58-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.69-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$87.27 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.45-300.57%๐Ÿ‡ซ๐Ÿ‡ท France